PoC Trial. Each PoC Trial will be conducted in accordance with the PoC Trial Design set forth in the applicable Initial Development Plan.
(i) At meetings of the applicable Neurology JDC, Isis will keep Biogen Idec informed of the progress and status of each PoC Trial conducted by Isis. When Isis [***] a PoC Trial under the applicable Initial Development Plan, Isis will notify Biogen Idec in writing within [***] days after such measurement. Isis will provide Biogen Idec with the [***] as soon as practicable after such notice.
(ii) If Biogen Idec exercises its Option prior to the Initiation of the first PoC Trial for a Collaboration Program or if Biogen Idec conducts the first PoC Trial for an ALS Collaboration Program, then at meetings of the applicable Neurology JDC Biogen Idec will keep Isis informed of the progress and status of the PoC Trial for such Collaboration Program. When Biogen Idec completes such PoC Trial, Biogen Idec will notify Isis in writing within [***] days after such completion, and will provide Isis with [***] as soon as practicable after such notice.
PoC Trial. The PoC Trial will be designed in accordance with the PoC Trial Design set forth in the ISIS-DMPKRx R&D Plan. Isis will keep Biogen Idec informed of the progress and status of the PoC Trial. When Isis completes the PoC Trial under the ISIS-DMPKRx R&D Plan, Isis will notify Biogen Idec in writing within 30 days after such completion. Isis will provide Biogen Idec with [***] as soon as practicable after such notice. If Biogen Idec exercises the Option prior to the Initiation of the PoC Trial, Biogen Idec will keep Isis informed of the progress and status of the PoC Trial. When Biogen Idec completes the PoC Trial, Biogen Idec will notify Isis in writing within 30 days after such completion, and will provide Isis with [***] as soon as practicable after such notice.
PoC Trial. Cyferd may provide Customer with or make available to Customer use of the Cyferd Product (or any part of it including any App(s) and Feature(s)) for the purposes of a POC Trial. Such use of the Cyferd Product for the purposes of a POC Trial is subject to any additional terms (including any applicable Fees payable during such POC Trial and/or additional Access/Usage Parameters) that Cyferd specifies and is only permitted during the period Cyferd expressly designates for such purpose (or, if not so expressly designated, until terminated in accordance with this Agreement). Without limiting anything else herein, Cyferd expressly disclaims any representations or warranties, express or implied, or indemnities and/or liabilities in connection with such POC Trial, and all Access to the Cyferd Product during such POC Trial is provided “As Is, Where is, Without Fault” without indemnification, maintenance, support, or warranty of any kind, express or implied. Except as expressly set out to the contrary in this Agreement and any applicable Order Form, the terms of this Agreement fully apply in respect of a POC Trial. Cyferd may modify or terminate Customer’s use of the Cyferd Product (or any part of it) for the purposes of a POC Trial at any time and for any reason in Cyferd’s sole discretion, without liability to Customer, and Customer may cancel at any time without charge prior to the expiration of such POC Trial. Use of the Cyferd Product (or any part of it) for the purposes of a POC Trial will be time limited (set by Cyferd at its sole discretion) and in a non-production environment and this is an Access/Usage Parameter. Use of the Cyferd Product (or any part of it) for the purposes of a POC Trial does not need to be but can be the subject of an Order/Order Form. By Customer using the Cyferd Product (or any part of it) for the purposes of a POC Trial it shall be deemed to be Customer accepting this Agreement in respect of the same. NOTWITHSTANDING ANYTHING ELSE IN THESE TERMS, CYFERD’S MAXIMUM AGGREGATE LIABILITY TO CUSTOMER IN RESPECT OF CUSTOMER’S ACCESS TO AND/OR USE OF A POC TRIAL WILL BE $500.
PoC Trial. Each PoC Trial will be conducted in accordance with the PoC Trial Design set forth in the applicable Development Plan. Ionis will keep Biogen informed of the progress and status of each PoC Trial. When Ionis [***] a PoC Trial under the applicable Development Plan, Ionis will notify Biogen in writing within [***] days after such [***]. Ionis will provide Biogen with the [***] as soon as practicable after such notice. If Biogen exercises its Option prior to the Initiation of the first PoC Trial for a Collaboration Program, Biogen will keep Ionis informed of the progress and status of the PoC Trial for such Collaboration Program. When Biogen completes such PoC Trial, Biogen will notify Ionis in writing within [***] days after such completion, and will provide Ionis with [***] as soon as practicable after such notice.
PoC Trial. Each PoC Trial will be designed in accordance with the applicable PoC Trial Design set forth in the ISIS-SMNRx Development Plan. Isis will keep Biogen Idec informed of the progress and status of each PoC Trial. When Isis completes a PoC Trial under the ISIS-SMNRx Development Plan, Isis will notify Biogen Idec in writing within 30 days after such completion. Isis will provide Biogen Idec with [***] as soon as practicable after such notice.
